Global Epilepsy Market Highlights Over 2022 – 2031

The global epilepsy market is estimated to grow with a CAGR of ~8% over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a notable revenue in the year 2021. The growth of the market can be attributed to the increase in the aged population that is more prone to epilepsy disorder as compared to the younger generation. Moreover, there has been growing awareness related to epilepsy among people which is also anticipated to drive market growth. According to the World Health Organization, approximately 50 million people across the globe are suffering from epilepsy disorder with nearly 80 percent of them are living in middle- and low-income countries.

GET A SAMPLE COPY OF THIS REPORT
 

The COVID-19 pandemic had a negative impact on people suffering with epilepsy. The healthcare facilities were limited to COVID-19-infected patients owing to the risk of disease transfer from one person to another. Moreover, the pandemic is known to worsen the health conditions of epilepsy patients considering the symptoms such as fever, tiredness, and cough. Therefore, the demand for epilepsy care increased during the pandemic.

The global epilepsy market is segmented by treatment & diagnosis into treatment and diagnosis. Out of these, the diagnosis segment is anticipated to hold the largest share over the forecast period in the global epilepsy market. This can be attributed to the rise in awareness among people for early diagnosis of epilepsy in the form of blood and imaging tests that can help in finding out the abnormality in the brain.

Global Epilepsy Market Regional Synopsis

Regionally, the global epilepsy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. On the strength of the presence of healthcare-supportive government policies and established healthcare infrastructure, the market in the North America region is anticipated to hold the largest share by the end of 2031. Moreover, the market in Asia Pacific region is estimated to witness modest growth over the forecast period on the back of an increase in the aged population, increase in healthcare expenditure, and a rise in spending on research and development. As per the World Bank, the percentage of the population aged 65 and above increased from 3% of the total population in 1960 to 7% of the total population in 2020.

Market Segmentation

Our in-depth analysis of the global epilepsy market includes the following segments:

By End-Use

• Diagnostic Centers

• Hospitals

• Clinics

• Ambulatory Surgical Centers

• Others

By Treatment & Diagnosis

• Treatment

• Diagnosis

Growth Drivers and Challenges Impacting the Growth of the Global Epilepsy Market

Growth Drivers

• Increase in the aged population

• Rise in the awareness related to epilepsy

Challenges

• Increasing cost of medicine

• Lack of skilled healthcare workers

Key Companies Dominating the Global Epilepsy Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global epilepsy market that are included in our report are NeuroPace, Inc., Pfizer Inc., LivaNova PLC, Abbott., Jazz Pharmaceuticals plc (GW Pharmaceuticals), Novartis AG, Johnson & Johnson Services, Inc., Medtronic, Eisai Co., Ltd., GlaxoSmithKline plc., and others.

Latest Developments in the Global Epilepsy Market:

• 31 August 2020: NeuroPace, Inc., announced it has raised USD 67 million in funding to support the commercialization of the RNS System for Refractory Epilepsy.

• 1 April 2022: Eisai Co., Ltd. announced the acquisition of Arteryex Inc., to strengthen to rapidly expand and strengthen the foundation of its digital solution business in the field of healthcare.

Key Reasons to Buy Our Report

• The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

• It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.

• The report includes detailed company profiles of the major players dominating the market.

• We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.

• We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.